In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Israeli Court Snags Sun Pharma Of India Plan To Buy Taro

This article was originally published in PharmAsia News

Executive Summary

The Israeli Supreme Court has called a temporary halt to the effort by India's Sun Pharma to acquire Israel's Taro Pharmaceuticals. The move is the latest of legal steps that have snagged the hostile takeover attempt. The high court upheld a lower court ruling that blocked Sun's expiration date for shareholders to meet the Indian company's tender offer. The ruling effectively prevents Sun from closing the deal before a court appeal is resolved. The Supreme Court set a Dec. 8 date for opening arguments. (Click here for more
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC069527

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel